What is it about?
Efforts to treat Type 1 diabetes; Effects on the immune system
Featured Image
Why is it important?
Completely new type of therapy giving autoantigen into the lymph nodes. Can hopefully preserve residual insulin secretion
Perspectives
Ongoing studies will give further results
Senior Professor Johnny Ludvigsson
Linkopings universitet
Read the Original
This page is a summary of: Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes, Journal of Diabetes Research, January 2018, Hindawi Publishing Corporation,
DOI: 10.1155/2018/9391845.
You can read the full text:
Contributors
The following have contributed to this page
